{"id":624369,"title":"Consultation on the Prescription Drug List: Hydroquinone - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T00:54:07.482000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-prescription-drug-list-hydroquinone.html","snippet":"Consultation on the Prescription Drug List: Hydroquinone The purpose of this Notice of Consultation is to provide an opportunity to comment on the proposal to add hydroquinone to the Prescription Drug List (PDL) when sold in a concentration greater than 2% in topical products.…","rawSnapshotUrl":"/api/snapshots/raw/624369","browseUrl":"https://replay.healtharchive.ca/job-6/20260227005407/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-prescription-drug-list-hydroquinone.html#ha_snapshot=624369","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}